Feasibility of a Noncontact Photoplethysmography-Based Mobile App for Noninvasive Hemoglobin Monitoring: Exploratory Observational Study.

Gianvincenzo Zuccotti, Paolo Agnelli, Lucia Labati, Erika Cordaro, Davide Braghieri, Paolo Fiorina, Simona Bertoli, Cesare Celeste Federico Berra, Marina Croci, Maria Elena Malighetti, Fabrizio Losurdo, Andrea Foppiani, Loredana Bucciarelli, Marco Xodo, Alberto Battezzati, Sergio De Pasquale, Valeria Calcaterra

Journal: JMIR formative research 2026;10():e78820

PMID: 41712961

Abstract

BACKGROUND

Anemia is a widespread global health issue. Hemoglobin (Hb) concentration measurement remains the most common method for anemia screening and diagnosis. In recent years, there has been growing interest in the development of noninvasive point-of-care technologies that eliminate the need for blood sampling.

OBJECTIVE

This pilot study explores the feasibility of using a noncontact photoplethysmography-based mobile app for Hb monitoring.

METHODS

Adult volunteers aged 18 years and older, of both sexes, were consecutively recruited. Participants were seated and allowed a 2-minute rest before measurements. During testing, they faced a smartphone running comestai.app, which used the front-facing camera to capture facial videos. Simultaneous readings were collected for Hb over approximately 90 seconds using the app. Ambient lighting was standardized for all remote photoplethysmography recordings. No medical decisions were made based on the app-generated data. A complete blood count, including Hb levels, was used as a reference for comparison with the data collected using comestai.app.

RESULTS

A total of 555 (female: n=313, 56.4%; male: n=242, 43.6%) individuals participated in the study. The app achieved a mean absolute error of 1.46, a mean absolute percentage error of 11.26, a mean error of -0.67, and a root mean square error of 1.88. The Bland-Altman plot evaluated the agreement between the app-based and laboratory-based Hb measurements, with the mean difference between the 2 methods being -0.70 g/dL. The method demonstrated an overall accuracy of 75%. The area under the curve was 0.701 (95% CI 0.655-0.745).

CONCLUSIONS

Comestai.app offers an innovative approach to wellness monitoring by providing noninvasive Hb estimation using the smartphone's front-facing camera. Continued development, including algorithmic refinement and larger-scale validation in diverse populations, will be key to enhancing accuracy and broadening its utility. By leveraging the ubiquity of smartphones, comestai.app contributes meaningfully to the democratization of health monitoring and the promotion of proactive self-care.

© Gianvincenzo Zuccotti, Paolo Agnelli, Lucia Labati, Erika Cordaro, Davide Braghieri, Paolo Fiorina, Simona Bertoli, Cesare Celeste Federico Berra, Marina Croci, Maria Elena Malighetti, Fabrizio Losurdo, Andrea Foppiani, Loredana Bucciarelli, Marco Xodo, Alberto Battezzati, Sergio De Pasquale, Valeria Calcaterra. Originally published in JMIR Formative Research (https://formative.jmir.org).

Address: Department of Biomedical and Clinical Science, University of Milan, Via GB Battista 32, Milan, 20154, Italy, 39 0263635321.; Pediatric Department, Buzzi Children's Hospital, Milan, Italy.; Come Stai S.p.A., Milan, Italy.; Pediatric Department, Buzzi Children's Hospital, Milan, Italy.; Department of Internal Medicine, Pediatric and Adolescent Unit, University of Pavia, Pavia, Italy.; Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.; Department of Biomedical and Clinical Science, International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, University of Milano, Milan, Italy.; Department of Food, Environmental and Nutritional Sciences (DeFENS), International Center for the Assessment of Nutritional Status and the Development of Dietary Intervention Strategies (ICANS-DIS), University of Milan, Milan, Italy.; Department of Endocrine and Metabolic Diseases, Laboratory of Nutrition and Obesity Research, IRCCS Istituto Auxologico Italiano, Milan, Italy.; Dipartimento Cardiovascolare e Metabolico, IRCCS MultiMedica, Sesto San Giovanni-Milano, Milan, Italy.; Department of Endocrine and Metabolic Diseases, Laboratory of Nutrition and Obesity Research, IRCCS Istituto Auxologico Italiano, Milan, Italy.; Ambulatorio di Diabetologia, Casa di Cura Ambrosiana, Cesano Boscone, Milan, Italy.; Department of Food, Environmental and Nutritional Sciences (DeFENS), International Center for the Assessment of Nutritional Status and the Development of Dietary Intervention Strategies (ICANS-DIS), University of Milan, Milan, Italy.; Department of Endocrine and Metabolic Medicine, Clinical Nutrition Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy.; Department of Biomedical and Clinical Science, International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, University of Milano, Milan, Italy.; Pio Albergo Trivulzio, Milan, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.